Search





Search





Markets
/
Stocks
/
nasdaq-avln
/

Avalyn Pharma Ord Shs (Proposed)

AVLN

Add to Watchlist

30.170USD

-2.750-8.35%

Close 07/01, 16:00（ET）Quotes delayed by 15 min

1.46BMarket Cap

--P/E TTM

Avalyn Pharma Ord Shs (Proposed)

30.170

-2.750-8.35%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can find the annual or quarterly income statement of Avalyn Pharma Ord Shs (Proposed) here for insights into the performance and operational efficiency of Avalyn Pharma Ord Shs (Proposed).

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating expenses

--27.91M

R&D expenses

--22.89M

Depreciation, depletion, and amortization

--63.00K

Operating profit

---27.91M

Net non-operating interest income (expenses)

Non-operating interest income

--1.13M

Non-operating interest expense

--98.00K

Special income (expenses)

---122.00K

Other non-operating income (expenses)

--13.00K

Income before tax

---26.87M

Income tax

--0.00

Income after tax

---26.87M

Net income from continuous operations

---26.87M

Net income attributable to controlling interests

---26.87M

Net income attributable to common shareholders

---26.87M

Basic earnings per share

---21.83

Diluted earnings per share

---21.83

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.